Blockade of glucagon signaling prevents or reverses diabetes onset only if residual β-cells persist
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Blockade of glucagon signaling prevents or reverses diabetes onset only if residual β-cells persist
Authors
Keywords
-
Journal
eLife
Volume 5, Issue -, Pages -
Publisher
eLife Sciences Organisation, Ltd.
Online
2016-04-19
DOI
10.7554/elife.13828
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Short-term administration of the glucagon receptor antagonist LY2409021 lowers blood glucose in healthy people and in those with type 2 diabetes
- (2015) R. P. Kelly et al. DIABETES OBESITY & METABOLISM
- Acute disruption of glucagon secretion or action does not improve glucose tolerance in an insulin-deficient mouse model of diabetes
- (2015) Vivi R. Steenberg et al. DIABETOLOGIA
- Islet α cells and glucagon—critical regulators of energy homeostasis
- (2015) Jonathan E. Campbell et al. Nature Reviews Endocrinology
- Glucagon receptor antibody completely suppresses type 1 diabetes phenotype without insulin by disrupting a novel diabetogenic pathway
- (2015) May-Yun Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Absence of Glucagon and Insulin Action Reveals a Role for the GLP-1 Receptor in Endogenous Glucose Production
- (2014) Lucy S. Jun et al. DIABETES
- Diabetes recovery by age-dependent conversion of pancreatic δ-cells into insulin producers
- (2014) Simona Chera et al. NATURE
- RETRACTED: Betatrophin: A Hormone that Controls Pancreatic β Cell Proliferation
- (2013) Peng Yi et al. CELL
- Fibroblast Growth Factor 21 (FGF21) and Glucagon-Like Peptide 1 Contribute to Diabetes Resistance in Glucagon Receptor-Deficient Mice
- (2013) B. A. Omar et al. DIABETES
- Liver-Specific Disruption of the Murine Glucagon Receptor Produces -Cell Hyperplasia: Evidence for a Circulating -Cell Growth Factor
- (2012) C. Longuet et al. DIABETES
- Persistence of Prolonged C-peptide Production in Type 1 Diabetes as Measured With an Ultrasensitive C-peptide Assay
- (2012) L. Wang et al. DIABETES CARE
- Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover
- (2012) Roger H. Unger et al. JOURNAL OF CLINICAL INVESTIGATION
- Metabolic manifestations of insulin deficiency do not occur without glucagon action
- (2012) Y. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hypoglycemia, hyperglucagonemia, and fetoplacental defects in glucagon receptor knockout mice: a role for glucagon action in pregnancy maintenance
- (2011) Sophia Ouhilal et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Polyomic profiling reveals significant hepatic metabolic alterations in glucagon-receptor (GCGR) knockout mice: implications on anti-glucagon therapies for diabetes
- (2011) Jianxin Yang et al. BMC GENOMICS
- Glucagon Receptor Knockout Prevents Insulin-Deficient Type 1 Diabetes in Mice
- (2011) Y. Lee et al. DIABETES
- Novel insight into glucagon receptor action: lessons from knockout and transgenic mouse models
- (2011) P. M. Vuguin et al. DIABETES OBESITY & METABOLISM
- The role of dysregulated glucagon secretion in type 2 diabetes
- (2011) D. D'Alessio DIABETES OBESITY & METABOLISM
- Chronic treatment with a glucagon receptor antagonist lowers glucose and moderately raises circulating glucagon and glucagon-like peptide 1 without severe alpha cell hypertrophy in diet-induced obese mice
- (2011) J. Mu et al. DIABETOLOGIA
- Dual elimination of the glucagon and GLP-1 receptors in mice reveals plasticity in the incretin axis
- (2011) Safina Ali et al. JOURNAL OF CLINICAL INVESTIGATION
- Single dose streptozotocin-induced diabetes: considerations for study design in islet transplantation models
- (2011) M C Deeds et al. LABORATORY ANIMALS
- Glucagon receptor antagonist-mediated improvements in glycemic control are dependent on functional pancreatic GLP-1 receptor
- (2010) Wei Gu et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Insulin Receptor Substrates Irs1 and Irs2 Coordinate Skeletal Muscle Growth and Metabolism via the Akt and AMPK Pathways
- (2010) Y. C. Long et al. MOLECULAR AND CELLULAR BIOLOGY
- Glucagon Deficiency Reduces Hepatic Glucose Production and Improves Glucose Tolerance In Adult Mice
- (2010) Aidan S. Hancock et al. MOLECULAR ENDOCRINOLOGY
- Conversion of adult pancreatic α-cells to β-cells after extreme β-cell loss
- (2010) Fabrizio Thorel et al. NATURE
- Paracrinology of islets and the paracrinopathy of diabetes
- (2010) R. H. Unger et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pancreatic neurogenin 3-expressing cells are unipotent islet precursors
- (2009) R. Desgraz et al. DEVELOPMENT
- Fully Human Monoclonal Antibodies Antagonizing the Glucagon Receptor Improve Glucose Homeostasis in Mice and Monkeys
- (2009) H. Yan et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Long-Term Inhibition of the Glucagon Receptor with a Monoclonal Antibody in Mice Causes Sustained Improvement in Glycemic Control, with Reversible -Cell Hyperplasia and Hyperglucagonemia
- (2009) W. Gu et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- A novel high-affinity peptide antagonist to the insulin receptor
- (2008) Lauge Schäffer et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started